This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. jumped 17.4% to $11.19 on what proved to be an all-around dismal trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,499.20 and the NASDAQ Composite Index falling 1.2% to 22,878.38.
This was the stock's fourth consecutive day of gains.
Novavax Inc. hit a new 52-week high, surpassing its previous peak of $10.64, which the company achieved on August 18th.
The stock outperformed some of its peers, as Johnson & Johnson fell 0.7% to $243.47, Pfizer Inc. remained unchanged, and Merck & Co. Inc. fell 2.58% to $119.30.
Trading volume totaled 23.9 million, compared to the 50-day average of 4.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 26, 2026 16:33 ET (21:33 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.